Here's Why April Could Be a Critical Month for Novavax
3/3 15:00
Novavax (NASDAQ: NVAX) has reached a major milestone. The biotech company surged past the vaccine-race finish line: It's won authorization for its vaccine in 38 countries, and now it's delivering doses around the world. This is the key to billion-dollar revenue this year....